Your biomolecules deserve better treatment.Pick your
industry:

Drug discovery

Diagnostics

They trust us

Kimialys, since 2020

Enabling Life Sciences through innovative biosensing solutions

In a nutshell.
‍Kimialys is an innovative industrial company specialized in biosensing, enabling laboratories worldwide to develop and produce tomorrow’s diagnostics and therapeutics. With over 100 projects delivered on complex real-world applications, we are contributing to the most innovative biotherapies and assays under development.

Your biomolecules deserve better treatment.
K-One is Kimialys’ proprietary surface chemistry, the functionalization platform behind all our products and services. This technology is a self-assembled monolayer (SAM) optimized for gold nanoparticles, chips, and electrodes, unlocking applications once out of reach due to technological limitations, and setting new standards in biosensing (detection, extraction, screening, characterization).

A team built for biosensing.
By combining K-One with our expertise in ligand functionalization, nanoparticle- and chip-based assays, and biosensor systems, we enable advanced applications in diagnostic development, drug discovery and bioanalysis. Our approach enhances key assay parameters, such as sensitivity, specificity, selectivity, reproducibility, and cost-effectiveness, without ever compromising one for another.

Explore our solutions

01

Event

Biophysics for Drug Discovery Summit

Join us at the 3rd Biophysics for Drug Discovery Summit, the go-to forum for industry biophysicists, from April 28 to 30, 2026.

Biophysics for Drug Discovery Summit

Let’s schedule a meeting

02

News

Kimialys raises a €3.6M series A

Kimialys has successfully raised a €3.6 million Series A, marking a significant milestone following its initial seed round nearly three years ago.

Kimialys raises a €3.6M series A

All the news

03

Article

Robustness and reproducibility of SPR chips functionalized with anti-Rabbit antibodies on K-One surface chemistry

Discover how Kimialys' K-One surface chemistry provides a reliable and robust solution for immobilizing anti-rabbit antibodies on SPR chips. This novel approach ensures consistent antibody capture and high reproducibility over multiple cycles, even with complex sample matrices.

Robustness and reproducibility of SPR chips functionalized with anti-Rabbit antibodies on K-One surface chemistry

All the articles

Stay informed of our latest activities:

Linkedin pictogram

Follow us on LinkedIn
Calendar pictogram

News & events
Articles pictogram

Our whitepapers & application notes

Let’s connect

Project in mind? Specific question? Or just an exploratory talk? Submit your message, and we'll get back to you as soon as we can.

Laboratory

Paris Biotech Santé Cochin – 4th floor
29 rue du Faubourg Saint Jacques, 75014 Paris

HQ

2 rue Dante, 75005, Paris, France

By checking this box, you consent to the storage of the information provided on this form in our database for the purpose of managing your request. This data is collected exclusively on behalf of Kimialys. In accordance with the GDPR (see our legal notices), you have the right to access, delete, and modify the information about you. You can exercise these rights by reaching out to: contact@kimialys.com.

Thank you for your interest! Our team will get back to you as soon as possible.
Oops! Something went wrong while submitting the form.

Join our newsletter to stay up to date on features and releases.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

Thank you! Your submission has been received.
Oops! Something went wrong while submitting the form.

SPR services

Custom K-One sensor chips

Antibody selection platform

LFA services

K-One gold bioconjugates

About K-One technology

Kimialys R&D

Whitepapers & application notes

By clicking on "Accept all cookies", you agree to the storage of cookies on your device to improve site navigation, analyze site usage and assist us in our marketing efforts. See our Cookie policy for more information.
PreferencesDeclineAccept